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The Health Insurance Portability and Accountability Act (HIPAA) Safe Harbor method requires removal of
18 types of protected health information (PHI) from clinical documents to be considered ‘‘de-identiﬁed’’
prior to use for research purposes. Human review of PHI elements from a large corpus of clinical docu-
ments can be tedious and error-prone. Indeed, multiple annotators may be required to consistently redact
information that represents each PHI class. Automated de-identiﬁcation has the potential to improve
annotation quality and reduce annotation time. For instance, using machine-assisted annotation by com-
bining de-identiﬁcation system outputs used as pre-annotations and an interactive annotation interface to
provide annotators with PHI annotations for ‘‘curation’’ rather than manual annotation from ‘‘scratch’’ on
raw clinical documents. In order to assess whether machine-assisted annotation improves the reliability
and accuracy of the reference standard quality and reduces annotation effort, we conducted an annotation
experiment. In this annotation study, we assessed the generalizability of the VA Consortium for Healthcare
Informatics Research (CHIR) annotation schema and guidelines applied to a corpus of publicly available
clinical documents called MTSamples. Speciﬁcally, our goals were to (1) characterize a heterogeneous cor-
pus of clinical documents manually annotated for risk-ranked PHI and other annotation types (clinical
eponyms and person relations), (2) evaluate how well annotators apply the CHIR schema to the heteroge-
neous corpus, (3) compare whether machine-assisted annotation (experiment) improves annotation
quality and reduces annotation time compared to manual annotation (control), and (4) assess the change
in quality of reference standard coverage with each added annotator’s annotations.
Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creative-
commons.org/licenses/by-nc-nd/3.0/).1. Introduction
In most electronic medical record (EMR) systems, a great deal of
relevant clinical information is stored in clinical documents.
Clinical documents and other medical records data are rich in
protected health information (PHI). Preserving a patient’s privacy
and conﬁdentiality of PHI is fundamental to the physician-patient
relationship. In order to use patient medical records for purposes
other than providing health care (e.g. clinical research), informedconsent from the patient is required. Indeed, use of patient medical
record data is subject to the ethical and legal considerations
deﬁned by the Health Insurance Portability and Accountability
Act (HIPAA) codiﬁed as 45 CFR §160 and 164 and the Common Rule
[1]. However, obtaining the informed consent of a large population
of patients, especially for retrospective research is difﬁcult, time-
consuming, and costly. This requirement can be waived if clinical
documents are de-identiﬁed (i.e., all information identifying the
patient has been redacted). Although de-identiﬁcation of clinical
documents remains a signiﬁcant challenge, fulﬁlling these ethical
and legal requirements is often a necessary step prior to using
them for clinical research. However, manually de-identifying
clinical documents represents a considerable expense in terms of
time and human workload.
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(NLP) techniques may reduce the time and effort required to
manually de-identify clinical documents, especially for large-scale
projects applied to tens of thousands of patient records in which
manual redaction of PHI is impractical. An NLP de-identiﬁcation
system must accurately remove the 18 types of PHI identiﬁers
speciﬁed under the HIPAA Safe Harbor method for clinical
documents to be considered ‘‘de-identiﬁed’’. NLP systems that
de-identify clinical documents are readily available [2–17], but
are often developed and evaluated using speciﬁc document types.
The approaches used by these systems may not be generalizable to
all document types due to document speciﬁc formatting, clinical
sublanguages, and prevalence of PHI [2]. Indeed, there is always
the possibility that even with ‘‘de-identiﬁed’’ documents a PHI
identiﬁer may slip by and not be removed by all review methods
[18]. A combined approach may reduce the likelihood of missing
PHI identiﬁers and achieve acceptable coverage for certain PHI
types by combining the efforts of many human reviewers with
the outputs of an NLP system used as pre-annotations [19–21].
By leveraging NLP system outputs, this approach could offer a
lower cost solution by pre-annotating potential PHI identiﬁers that
human annotators review i.e., modifying existing, adding missing,
or deleting spurious machine annotations. However, with any
human review task relying on understanding of guidelines and
tools, the cost of manual effort is high and may produce marginal
returns of improved coverage as additional reviewers are added.
The number of judges required to achieve acceptable coverage
may also correlate with the risk of re-identiﬁcation for different
PHI types.
In this study, we evaluate the effects of a combined machine
pre-annotation plus interactive annotation interface used to de-
identify clinical documents from a publicly accessible document
corpus called MTSamples. This heterogeneous clinical document
corpus was selected for this study because it is a publicly available
data source that could be easily obtained without a rigorous
institutional data release process and contains replaced PHI men-
tions in context (‘‘Dr. Sample Doctor. . .’’) that are useful for de-
identiﬁcation research. We ﬁrst describe the MTSamples corpus.
We then describe an annotation experiment including the annota-
tion scheme used and training process. Finally, we further detail
our annotation training, experiment, and evaluation approaches
and assess the effects of combining machine pre-annotation plus
an interactive annotation interface used to de-identify clinical
documents.2. Background
Creating a reference standard that adequately identiﬁes all
HIPAA PHI identiﬁer types and provides accurate training and eval-
uation data is imperative for developing rule-based or machine-
learning-based de-identiﬁcation systems. A few NLP researchers
have championed efforts to facilitate the creation of state-of-
the-art de-identiﬁcations for clinical documents and evaluate such
systems against a standard corpus [16]. In 2006, NLP researchers
from the University of Albany and MIT CSAIL sponsored the 2006
i2b2 Challenge task for automatic de-identiﬁcation of clinical doc-
uments. A corpus of 889 discharge summaries from Partners
Healthcare was annotated in two phases. In phase 1, PHI of eight
types – patient names, doctor names, hospital names, IDs, dates,
locations, phone numbers, and ages – were pre-annotated using
an automated de-identiﬁcation system that applied machine
learning approaches [17]. In phase 2, three annotators sequentially
annotated each report using a serial review method and achieved
consensus after each review round. The inter-annotator agreement
(IAA) between annotators and the performance of the NLPde-identiﬁcation system was not reported as part of the 2006
i2b2 Challenge [16].
In contrast to the 2006 i2b2 Challenge, the goal for our manual
de-identiﬁcation task was to estimate the effects of machine pre-
annotations and an interactive annotation interface on human
annotator performance and quality of generated data for a hetero-
geneous clinical document corpus. We compare and contrast
between annotators and the generated reference standard using
IAA and standard performance metrics (i.e. recall, precision, and
F1-measure) to assess annotator task consistency and accuracy.
The effects of pre-annotation on the quality of annotated data
has been investigated in many studies that include annotation of
medical literature [20], POS tagging [19], named entity recognition
(NER) [22] and clinical named entities [23,24], as well as common
PHI types [25]. Other studies have employed semi-automated
annotation methods that produce machine-generated candidate
spans presented in such a way that the human reviewer must
either modify incorrect annotations, delete spurious annotations,
or add missed annotations [26–28]. It was our goal to produce a
corpus of clinical documents annotated for PHI that maximized
annotation quality while minimizing annotation effort.3. Methods
We begin by describing the annotated MTSamples corpus. Next,
we describe an annotation experiment including the annotation
schema and training process. We further detail our annotation
training, experiment, and evaluation approaches.
3.1. MTSamples corpus
A document sample consisting of 2,330 unique clinical docu-
ments was obtained from a publicly available resource of clinical
documents called MTSamples (Medical Transcription Samples at
www.mtsamples.com). These clinical documents were originally
created to train medical coders and transcriptionists. The sample
corpus contains document samples from 40 different medical
specialties – consults, discharge summaries, and specialized med-
ical services – including some uncommon formats. Although the
MTSamples corpus does include data representing most of the 18
types of PHI identiﬁers speciﬁed under the HIPAA regulation,
names and dates that remain have been changed (or removed) to
preserve conﬁdentiality of the users providing the data.
3.2. Annotation schema
We build upon previous efforts [29] by expanding PHI types
deﬁned as part of the 2006 i2b2 challenge [16] and deﬁnitions
for the Veteran Affair’s (VA) setting using an annotation schema
and guidelines originally developed as part of the VA Consortium
for Healthcare Informatics Research (CHIR) De-identiﬁcation pro-
ject [8,11]. These annotation guidelines go beyond the PHI types
annotated from the 2006 i2b2 Challenge. We include annotation
types representing clinical eponyms, organization names, military
deployments, health care units, and co-referring-paired relation-
ships between annotations for person names (Table 1). For exam-
ple, ‘‘Patient Joe Smith. . . and Mr. Smith. . .’’, ‘‘Joe Smith’’ and
‘‘Smith’’ might refer to the same person, in which case they would
be linked in a paired relationship.
Our motivation to include annotation of clinical eponyms was
twofold. First, we wished to measure human performance identify-
ing clinical information that machine systems may misclassify as
PHI. Second, we wished to enrich available data sources for train-
ing classiﬁers and methods to identify these information types.
Human reviewers more easily identify this type of information
Table 1
Annotation type deﬁnitions between i2b2 and extended CHIR Schema. Annotation types having co-referring relationships.
i2b2 PHI types
[16]
Deﬁnitions Extended CHIR
Annotation Types
[8,11]
Deﬁnitions
Dates All elements of a date except for the year Dates Date, including year and/or time, and speciﬁc time of day. Ex. ‘‘clinic on
July 4, 2001@01:00’’. This does not include mentions of durations. Ex.
‘‘2 h’’, ‘‘5 days’’, ‘‘day 1’’, ‘‘x2’’.
Patients First and last names of patients, their
health proxies, and family members
Patient Names Patient’s ﬁrst name, last name, middle name, and initials excluding
salutations. Ex. ‘‘Mr. Smith complains of cough’’
Relative Names Proper name of relatives. Ex. ‘‘patient’s daughter Jennifer’’
Other Person Names Other persons mentioned or patient proxy. Ex. ‘‘lived in his friend Mike’s
place’’
Doctors Medical doctors and other practitioners as
well as transcriber’s name and initials
Health Care Provider
Names
Health care worker’s ﬁrst name, last name, middle name, and initials
excluding salutations Ex. ‘‘JONES, JANE MD’’
Ages Ages above 89 All mentions of age Expanded to include all mentions of age. Ex. ‘‘52-year-old man’’
IDs Any combination of numbers, letters, and
special characters identifying medical
records, patients, doctors, or hospitals
Other ID Numbers All combinations of numbers and letters that could represent a medical
record number, lab test number, or other patient or provider identiﬁer such
as driver’s license number. Ex. ‘‘Driver’s license: S-012-34567’’
Electronic Addresses Electronic mail addresses and references to personal Websites, Facebook
pages, Twitter. Ex. ‘‘CC: smarty@yahoo.com’’
Social Security
Numbers
Numbers and/or characters, that could represent a social security reference.
Ex. ‘‘SSN is 000-00-0000’’
Locations Geographic locations such as cities, states,
street names, zip codes, building names,
and numbers
Street City Street or city names excluding name as part of organization name. Ex.
‘‘lived on 5 Main Street’’
State Country State or country. Ex. ‘‘lived in Alaska’’
Zip codes All digits acting as a zipcode. Ex. ‘‘works in 08536 area’’
Deployments A speciﬁc geographic location, or mention of unit, battalion, regiment,
brigade etc. Ex. ‘‘deployed with the 81st infantry unit’’
Hospitals Names of medical organizations and of
nursing homes where patients are treated
and may also reside including room
numbers of patients, and buildings and
ﬂoors related to doctors’ afﬁliations
Other Organization
Names
Afﬁliation with companies such as employment that are not related to
health care. Ex. ‘‘employed by WalMart’’
Health Care Unit
Names
Sub-specialty clinics, consults or referral to services, or recommendations
from services where health care was or will be provided to a patient. Ex
‘‘Care provided at VA SALT LAKE CITY HCS’’
Phone Numbers Telephone, pager, and fax numbers Phone Numbers Phone/fax/pager numbers including phone number extensions. Ex. ‘‘Fax
No: 381-7777’’
Non-PHI Not annotated as part of i2b2 Clinical eponyms as
part of medical
procedure names
Medical procedures that contain proper names of persons, places, or
locations. Ex. ‘‘DeLuca criteria was used’’
Non-PHI Not annotated as part of i2b2 Clinical eponyms as
part of medical device
names
Medical devices that contain proper names of persons, places, or locations
excluding brand names. Ex. ‘‘Foley catheter’’
Non-PHI Not annotated as part of i2b2 Clinical eponyms as
part of disease names
Diseases that contain proper names of persons, places, or locations. Ex.
‘‘history of Crohn’s disease’’
Non-PHI Not annotated as part of i2b2 Clinical eponyms as
part of anatomic
structures
Anatomic structures contain proper names of persons, places, or locations.
Ex. ‘‘Achilles tendon’’
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contextual cues that may not be integrated with machine learned
systems. We show a logical representation of these annotation
types in Fig. 1.
For each annotation type, we developed detailed guidelines
specifying inclusion and exclusion criteria regarding what to mark
and not mark, which tokens to include, and what type of
information should be marked. Annotations were deﬁned using a
contiguous span, beginning at the start of a phrase and ending at
the completion of the phrase to capture instances rather than
individual word tokens.
3.3. Experimental design
Manual annotation can be a slow, laborious process. We per-
formed an experiment to determine the effects of combining
machine pre-annotations with an interactive annotation interface.
It was our goal to maximize annotation quality while minimizingmanual annotation effort. We also wished to limit confusion or
uncertainty related to annotator training on the guidelines,
schema, and tool while maximizing the number of documents
annotated from the original 2,330 MTSamples document corpus.
This was achieved by separating annotation of the MTSamples cor-
pus into annotator training and experiment. A stratiﬁed random
sample was obtained for both training and experiment based on
document type and the number of lines, words and tokens found
in each clinical document. During the annotator training, seven
reviewers annotated a random sample of 350 documents divided
into 15 batches of 20–25 documents. Annotator training continued
until a reviewer either exhausted their supply of training docu-
ments/batches or achieved a pre-deﬁned IAA performance thresh-
old of 75% or greater when compared to other annotators on the
training corpus. During the annotator experiment, the same seven
reviewers annotated another random sample of 1,535 documents
divided into 15 batches of 35 documents. Each annotator reviewed
a total of 525 documents with 1,229 (80%) of these annotated by
Fig. 1. Logical representation of the annotation schema. Annotation types color-coded by PHI privacy risk ranking: red (high risk), orange (medium risk), yellow (low risk),
and gray (non-PHI). Co-referring paired relationships were created between annotations for person names. (For interpretation of the references to colour in this ﬁgure legend,
the reader is referred to the web version of this article.)
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ment, annotators applied the same guidelines and annotation
schema using an annotation tool called the extensible Human Ora-
cle Suite of Tools (eHOST) [27]. Following the annotator training
and experiment, a ﬁnal reference standard was created after
adjudicating discrepancies and consensus review of the resulting
annotations from all reviewers.
During the annotator experiment, we employed two types of
machine-assisted annotation: (1) machine pre-annotations (pre-
annotations generated using an out-of-the-box de-identiﬁcation
system) and (2) interactive annotation (interactive annotation
interface integrated with the annotation tool). We hypothesized
that a combined approach using machine pre-annotations and an
interactive annotation interface would reduce the time required
for manual annotation of annotation types deﬁned by our schema
and found in clinical texts and would not reduce the quality of
the data annotated. We used an ‘‘out-of-the-box’’ version of a de-
identiﬁcation system called BoB to generate pre-annotations, and
a function integrated with the eHOST tool called ‘‘the Oracle’’ to
provide the interactive annotation interface.
3.3.1. BoB: machine-generated pre-annotations from a
de-identiﬁcation system
One automated de-identiﬁcation system designed for clinical
documents is the Veterans Affairs ‘‘Best-of-Breed’’ (BoB) de-
identiﬁcation system [8]. BoB is a hybrid system that integrates
known high-performing approaches speciﬁc to each particular
PHI type from existing rule-based and machine learning systems.
BoB is developed on a UIMA framework and processes documents
using two main components: a high-sensitivity extractor and a
false positive ﬁlterer. The high-sensitivity extractor applies a con-
ditional random ﬁeld classiﬁer and rules to identify all potential
PHI annotations maximizing recall. The false positive ﬁlterer lever-
ages a support vector machine classiﬁer to reclassify incorrectly
tagged PHI annotations maximizing precision. For instance, the ﬁl-
terer may reclassify clinical eponyms such as those mentioned
within Anatomical Structures e.g., ‘‘Circle of Willis’’ as non-PHI.
We processed the MTSamples corpus using an out-of-the-boxversion of BoB originally trained on VA document types to generate
pre-annotations provided to annotators during the experiment.
Under these conditions, the annotation task is modiﬁed slightly
and the human annotator accepts correct pre-annotations, modi-
ﬁes incorrect spans and deletes incorrect pre-annotations. We
evaluate how helpful the system outputs could be without
additional training on the MTSamples document corpus, a reality
most researchers face when obtaining any open-source, de-
identiﬁcation software. We report recall, precision and F1-measure
and provide baseline ‘‘out-of-the-box’’ performance of BoB without
domain adaptation on the MTSamples corpus.
3.3.2. The eHOST Oracle: machine-assisted interactive annotation
interface
One function integrated with the eHOST tool is a module called
‘‘the Oracle’’. When enabled, the Oracle provides new annotation
suggestions to the annotator based on an exact string match of
the last human reviewer-produced annotation corresponding with
that annotation type. For instance, if an annotator spans ‘‘Jane’’ as a
Patient Name, the Oracle can search either the current document or
across an entire batch of documents for other spans of ‘‘Jane’’ and
then present these as potential candidate spans representing
Patient Name. The annotator can choose to accept or reject these
candidate PHI annotations. Annotators completed the annotator
training using the eHOST Oracle module and were accustomed to
its functionality before starting the annotator experiment dis-
cussed later. We report annotator utilization of the eHOST Oracle
module in comparison to the total number of annotations gener-
ated during the experiment.
3.4. Annotation prevalence
We characterized the ﬁnal reference standards generated from
the annotator training and experiment. We report prevalence and
performance metrics for PHI types speciﬁed by HIPAA and all anno-
tation types deﬁned in our annotation scheme. We further stratify
these analyses according to the following re-identiﬁcation risk
ranking in the case where PHI is potentially missed.
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Names, Other Person Names, and Health Care Provider Names.
Medium Risk: Dates, Street City, State Country, Zip codes,
Deployments, Other Organization Names, Other ID Numbers,
Phone Numbers, Electronic Addresses and Ages.
Low Risk: Health Care Unit Names.
Non-PHI: Clinical eponyms (Anatomic Structures, Devices,
Diseases, Procedures) and Person Relations.
3.5. Annotator performance metrics
We evaluated inter-annotator agreement (IAA) using F1-
measure as a surrogate for Kappa since the number of document
strings not annotated as a PHI annotation or true negatives (TN)
are unknown [30]. We applied three types of annotator compari-
sons using standard performance metrics:
BoB-Reference Standard: compare BoB-generated pre-annota-
tions and the reference standard generated during the annota-
tor training using average exact performance metrics (recall,
precision, F1-measure).
Annotator–Annotator: compare average paired exact and partial
IAA between annotators.
Annotator-Reference Standard: compare average exact and par-
tial performance metrics (i.e. recall, precision, F1-measure)
between annotators and the annotator experiment reference
standard.Fig. 2. Annotation experF1-measure was calculated using the harmonic mean of recall
(TP/(TP + FN)) and precision (TP/(TP + FP)), deﬁned as 2 ((recall * -
precision)/(recall + precision)). For example, during Annotator-
Reference Standard comparisons we deﬁned:
True Positive (TP): an annotation that exactly (exact) or partially
(partial) overlapped a reference standard annotation for the
same annotation type.
False Positive (FP): an annotator’s annotation that did not occur
as a reference standard annotation.
False Negative (FN): a reference standard annotation that did not
occur in the annotator’s annotations.
3.6. Annotation experiment
For the experiment, we assessed whether human annotators
provided with machine pre-annotations and an interactive inter-
face could generate similar quality data for span and classiﬁcation
of annotation type than without machine pre-annotations plus an
interactive interface. We created two versions of the corpus – one
with and one without BoB pre-annotated machine annotations and
two versions of the eHOST tool – one with and one without the
eHOST Oracle module. Annotators were randomly assigned 7
batches with pre-annotations plus the interactive annotation inter-
face and 8 batches without (Fig. 2). For each annotation type and
PHI risk of re-identiﬁcation ranking, we evaluated whether humanimental conditions.
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(experiment = BoB + eHOST Oracle) were able to generate data of
similar quality with human annotators that did not receive the
experiment (control = raw annotation). For this evaluation, we
used the Wilcoxon Rank Sum test (Mann–Whitney U) [31]. The
Wilcoxon Rank Sum test is a non-parametric test equivalent to a
parametric 2-sample t-test for determining whether median F1-
measures for the experiment are different than medians of the con-
trol (calculated for each annotation type and stratiﬁed by PHI risk
ranking). For signiﬁcance testing independent t-tests were used to
determine if there were differences in averaged F1-measure
between control and experiment for each annotator on each clini-
cal document. For all statistical analyses, we used a null hypothesis
stating there was no difference between the control and experi-
ment using a signiﬁcance level of 0.05.We calculated statistics (mean,
median, and quartiles) and signiﬁcance tests using SAS version 9.3.
3.7. Time comparison
Next, we hypothesized that human annotators receiving the
experimental condition (BoB + eHOST Oracle) could produce anno-
tations in less time (seconds) than human annotators under the
control condition (annotation on raw clinical documents). We
compared the average time per annotation for the experiment
and control conditions. These calculations were made using the
mean time between annotation spans using the timestamp for
each annotation type classiﬁcation within each document.
3.8. Coverage differences with added annotators
Finally, since our goal was to maximize annotation quality
while minimizing annotation effort, we wanted to estimate how
adding additional reviewers would affect recall, precision, and
F1-measure. During the annotator training, we assessed the effects
of annotation coverage as a function of adding additional review-
ers. All seven reviewers annotated the same 350 documents.
Discrepant annotations were adjudicated and a ﬁnal consensus
review was conducted to create a reference standard after the
completion of both annotator training and experiment.4. Results
We characterized prevalence of each PHI risk ranking and anno-
tation type by training and experiment. For the annotator experi-
ment, we report performance metrics for BoB compared with the
reference standard generated for annotator training. We also report
averaged IAA for annotators during the annotator experiment, and
performance metrics for annotators compared with the reference
standard generated at the completion of the annotator experiment.
We compared distributions of the ﬁnal annotations produced by
experimental and control conditions and report the effects of the
experiment applying the Wilcoxon Rank Sum test. Time-savings
introduced by the experiment were also calculated. We also deter-
mined the coverage differences for each added annotator based on
the annotation training reference standard. Finally, we report the
distribution of each annotation type generated during the training
and experiment using the complete annotated corpus.
4.1. Annotation prevalence
The majority of documents were annotated during the experi-
ment. Discordant annotations generated from the training and
experiment were adjudicated and subjected to a ﬁnal consensus
review. We characterized the prevalence of annotations by PHI risk
category and annotation type found in the ﬁnal reference standardin Table 2. PHI categorized as medium risk had the highest preva-
lence for both annotator training and experiment; PHI categorized
as high risk had the lowest prevalence for training and experiment.
Counts are expanded by annotation type for each collapsed risk
ranking. For each PHI risk ranking, the most common PHI types
represented Health Care Provider Names for high risk, Dates for
medium risk, and Healthcare Unit Names for low risk. The most pre-
valent clinical eponyms were medical Devices. It is important to
note that paired relations between person relations were quite
common (5% within the entire annotated corpus); the most preva-
lent were Health Care Provider Names and Patient Names. Some PHI
types, Social Security Numbers, Zip codes, and Electronic Addresses,
did not occur in the MTSamples data.
4.2. BoB-reference standard performance metrics
Baseline performance for out-of-the-box BoB pre-annotations
on the MTSamples experiment corpus using standard performance
metrics (recall, precision and F1-measure) was low when micro-
averaged across all annotation types (0.20, 0.42, 0.27), moderate
on medium risk (0.44 0.48, 0.46), but very low for high risk (0.17,
0.04, 0.07) and low risk (0.10, 0.76, 0.18) PHI types. This is in con-
trast to the published overall micro-averaged performance of BoB
trained on VA clinical documents averaged across all PHI types
(0.92, 0.86, 0.86) [8]. Highest performance on BoB pre-annotations
on the MTSamples corpus was for Dates (0.78, 0.80, 0.79), followed
by Other ID Numbers (0.34, 0.25, 0.29) and State Country (0.85, 0.18,
0.29). BoB’s lowest performance was on Other Person Names (1.0,
0.04, 0.09). There were a total of 8,181 BoB pre-annotations pro-
vided to annotators across the experiment document corpus and
over half of these were false positive annotations 67% with only
16% (2,899) of these left unmodiﬁed prior to ﬁnal adjudication
and consensus review. Indeed, human annotators were more likely
to delete BoB pre-annotations than modify or accept them. The
majority of false positive annotations introduced by BoB pre-
annotations were clinical eponyms that were incorrectly classiﬁed
as Health Care Unit Names 21% (1,740) and Other Person Names 27%
(2,237). The majority of false negative annotations corresponded
with Ages 10% (850) and Dates 3.5% (285).
Annotators used the eHOST Oracle for only 640 (3.6%) annota-
tions out of the total 17,643 annotations generated by all 7 anno-
tators in the experiment. Out of these annotations the eHOST
Oracle was used to mark 243 clinical eponyms, 145 Ages, 120
proper names of persons, and 104 Dates, which is not surprising
since these types of annotations can easily be found using exact
string matching and some are highly prevalent (Clinical Eponyms,
Ages, Dates) in the MTSamples corpus. The eHOST Oracle produced
only 16 false positive annotations (<1%), on those annotations
where it was used.
4.3. Annotator–annotator agreement
For all annotation types (Table 3), agreement was moderate for
exact IAA (control 0.75; experiment 0.66) and slightly higher for
partial IAA (control 0.79; experiment 0.69). For each PHI risk rank-
ing, both exact and partial IAA was higher for annotation on raw
documents, ranging from moderate IAA for low risk PHI to high
IAA for medium and high risk PHI. For Person Relations, the exper-
iment condition produced higher IAA than the control. Inter-
annotator agreement on raw document annotation ranged from
low (Other ID Numbers, Deployments, and Other Person Names) to
moderate (Phone Numbers, Other Organization Names, Health Care
Unit Names, and all clinical eponyms) to high (all other types).
Agreement on experiment documents ranged from low (Relative
Names, Phone Numbers, Other Organization Names, and Other Person
Names) to moderate (Street City, State Country, Other ID Numbers,
Table 2
Prevalence of annotation types and PHI risk category by annotator training and experiment for the ﬁnal reference standard.
Annotation prevalence training and experiment
Annotator training Annotator experiment
N % N %
Documents Reviewed 350 18.6 1,535 81.43
Annotation Type
High Risk 311 12.8 1,135 11.2
Social Security Numbers – – – –
Patient Names 86 3.5 248 2.5
Health Care Provider Names 204 8.4 860 8.5
Relative Names 17 <1.0 12 <1.0
Other Person Names 4 <1.0 15 <1.0
Medium Risk 1,220 50.2 4,357 43.2
Dates 630 26.0 2,305 22.8
Street City 24 1.0 119 1.2
State Country 33 1.4 95 1.0
Zip codes – – – –
Phone Number 2 <1.0 6 <1.0
Deployments 2 <1.0 1 <1.0
Other Organization Names 49 2.0 109 1.1
Electronic Addresses – – – –
Other ID Numbers 4 <1.0 178 1.8
Ages 476 19.6 1,544 15.3
Low Risk 110 9.0 469 4.6
Health Care Unit Names 110 9.0 469 4.6
Non-PHI 661 27.1 2762 27.4
Clinical Eponyms 661 27.1 2762 27.4
Anatomic Structures 44 1.8 164 1.6
Devices 412 16.9 1,622 16.1
Diseases 48 2.0 263 2.6
Procedures 157 6.5 713 7.1
Person Relations 129 5.3 456 4.5
Health Care Provider Names relations 66 2.7 287 2.8
Patient Names relations 61 2.5 167 1.66
Relative Names relations 2 <1.0 2 <1.0
Total Annotations 2,431 19.4 10,091 80.6
Overall 12,522
Bold is provided for super categories of annotation classes only and overall numbers within these tables.
Table 3
Inter-annotator agreement for the experiment.
Inter-annotator agreement (IAA) (experiment)
Exact (IAA) Partial (IAA)
Control: raw annotation Experiment: BoB + eHOST Oracle Control: raw annotation Experiment: BoB + eHOST Oracle
Annotation Type 0.75 0.66 0.79 0.69
High Risk 0.90 0.73 0.95 0.75
Social Security Numbers – – – –
Patient Names 0.87 0.40 0.91 0.80
Health Care Provider Names 0.90 0.91 0.95 0.92
Relative Names 0.8 0 0.8 0
Other Person Names 0.33 0.10 0.33 0.11
Medium Risk 0.81 0.76 0.85 0.60
Dates 0.84 0.75 0.86 0.76
Street City 0.82 0.44 0.84 0.44
State Country 0.78 0.35 0.79 0.46
Zip codes – – – –
Phone Numbers 0.50 0 0.50 0
Deployments 0.33 – 0.33 –
Other Organization Names 0.61 0.30 0.64 0.39
Electronic Addresses – – – –
Other ID Numbers 0.07 0.60 0.15 0.60
Ages 0.84 0.83 0.92 0.89
Low Risk 0.50 0.50 0.54 0.55
Health Care Unit Names 0.50 0.50 0.54 0.55
Non-PHI 0.64 0.63 0.67 0.65
Clinical Eponyms 0.64 0.63 0.67 0.65
Anatomic Structures 0.67 0.55 0.68 0.59
Devices 0.68 0.76 0.72 0.77
Diseases 0.62 0.67 0.65 0.67
Procedures 0.55 0.40 0.56 0.45
Person Relations 0.60 0.91 0.62 0.95
Bold is provided for super categories of annotation classes only and overall numbers within these tables.
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other types). It is worth noting that both exact (control 0.60; exper-
iment 0.91) and partial (control 0.62; experiment 0.95) IAA was
higher for person relations generated under the experimental
condition.4.4. Annotator-reference standard performance metrics
We report performance metrics (recall, precision, and F1-mea-
sure) using the reference standard generated during the annotation
experiment (Table 4). We observed high exact recall (control 0.82,
experiment 0.80), precision (control 0.91, experiment 0.81), and
F1-measure (control 0.86, experiment 0.81) between annotators,
with improved partial recall (control 0.84, experiment 0.84), preci-
sion (control 0.94, experiment 0.85), and F1-measure (control 0.89,
experiment 0.84). For each PHI risk category, similar to Annotator–
Annotator performance, both exact and partial metrics were higher
when annotating on raw clinical documents. These differences
were statistically signiﬁcant for all annotation types when compar-
ing averaged exact F1-measure for each annotator and annotated
clinical document between control (0.84, ±0.211) and experiment
(0.81, ±0.255), t(3.13) = 1363.5, p = 0.0018.4.5. Annotation experiment
We evaluated whether annotators provided with machine pre-
annotations plus an interactive interface (experiment) produced
annotations and annotation type classiﬁcation of similar quality as
compared to annotators reviewing raw clinical texts (control). In
Table 5, we show summary statistics for the control and
experimental conditions by annotation type stratiﬁed by PHI risk
category computed from the Wilcoxon Rank Sum test. Signiﬁcant
differences were observed when comparing raw annotation
(control) and annotation using BoB + eHOST Oracle (experiment).
Annotation on raw clinical documents provided higher quality dataTable 4
Performance metrics for control (raw annotation) and experimental (BoB + eHOST Oracle)
Performance metrics annotator (experiment)
Exact (recall, precision, F1-measure)
Control: raw annotation Experiment: BoB + eH
Annotation Type 0.82, 0.91, 0.86 0.80, 0.81, 0.81
High Risk 0.94, 0.96, 0.95 0.87, 0.74, 0.80
Social Security Numbers – –
Patient Names 0.95, 0.98, 0.96 0.78, 0.85, 0.81
Health Care Provider Names 0.94, 0.96, 0.95 0.90, 0.96, 0.93
Relative Names 0.82, 0.93, 0.88 0.50, 0.50, 0.50
Other Person Names 0.50, 0.80, 0.62 0.69, 0.06, 0.11
Medium Risk 0.85, 0.92, 0.88 0.82, 0.86, 0.84
Dates 0.86, 0.95, 0.90 0.84, 0.93, 0.88
Street City 0.88, 0.92, 0.90 0.92, 0.50, 0.65
State Country 0.80, 0.94, 0.86 0.83, 0.50, 0.62
Zip codes – –
Phone Numbers 0.50, 0.71, 0.59 1, 1, 1
Deployments 0.67, 0.67, 0.67 –
Other Organization Names 0.69, 0.81, 0.74 0.61, 0.53, 0.57
Electronic Addresses – –
Other ID Numbers 0.37, 0.46, 0.41 0.36, 0.54, 0.44
Ages 0.90,0.93,0.91 0.89, 0.93, 0.91
Low Risk 0.69, 0.75, 0.72 0.76, 0.54, 0.63
Health Care Unit Names 0.69, 0.75, 0.72 0.76, 0.54, 0.63
Non-PHI 0.75, 0.89, 0.81 0.74, 0.84, 0.96
Clinical Eponyms 0.75, 0.89, 0.81 0.74, 0.84, 0.96
Anatomic Structures 0.77, 0.83, 0.80 0.64, 0.82, 0.72
Devices 0.77, 0.91, 0.83 0.79, 0.88, 0.83
Diseases 0.76, 0.87, 0.81 0.81, 0.79, 0.80
Procedures 0.69, 0.85, 0.76 0.62, 0.73, 0.67
Person Relations 0.75, 0.93, 0.83 0.74, 0.89, 0.81
Bold is provided for super categories of annotation classes only and overall numbers wifor Patient Names, Other Person Names, Relative Names, Street City,
State Country,Other OrganizationNames, andHealth Care Unit Names.
4.6. Time comparison
There was no statistically signiﬁcant difference when compar-
ing times for annotation of raw clinical documents compared with
annotation of documents annotated under the experimental
conditions across all annotation types. Observed mean time in
seconds per annotation was 13.7 s for annotation on raw clinical
documents and 13.6 s for documents annotated using BoB + eHOST
Oracle. Although these differences were not signiﬁcant across all
annotation types, the mean time between annotations generated
using only the eHOST Oracle was 5.24 s.
4.7. Coverage differences with added annotators
In Fig. 3, we show the change in performance metrics as logical
combinations of reviewers are compared. Recall ranged from 0.66
(1 reviewer) plateauing at a high of 0.92 (7 reviewers). Alterna-
tively, precision decreased from 0.82 (1 reviewer), to a low of
0.61 for the union of all seven judges. F1-measures ranged from
0.73 (1 reviewer), 0.79 (2), 0.78 (3), 0.77 (4), 0.75 (5), 0.74 (6),
and 0.73 (7 reviewers). Document level F1-measure (not shown)
by PHI risk ranking ranged from 0.20 to 1.00 (mean = 0.96,
std = 0.12) for high risk, 0.11–1.00 (mean = 0.89, std = 0.17) for
medium risk, and 0.07–1.0 (mean = 0.81, std = 0.22) for low risk.5. Discussion
5.1. Annotation prevalence
For the annotator training and experiment the most prevalent
PHI category included those PHI types categorized as medium risk
and the least prevalent PHI types were those in the high risk. At theconditions.
Partial (recall, precision, F1-measure)
OST Oracle Control: raw annotation Experiment: BoB + eHOST Oracle
0.84, 0.94, 0.89 0.84, 0.85, 0.84
0.96, 0.98, 0.97 0.93, 0.78, 0.85
– –
0.96, 0.99, 0.98 0.91, 0.99, 0.95
0.97, 0.98, 0.97 0.93, 0.99, 0.96
0.88, 1.0, 0.94 1, 1, 1
0.50, 0.80, 0.62 0.81, 0.07, 0.13
0.88, 0.96, 0.92 0.86, 0.91, 0.88
0.88, 0.97, 0.92 0.86, 0.94, 0.90
0.89, 0.93, 0.91 0.93, 0.51, 0.66
0.80, 0.95, 0.87 0.96, 0.57, 0.72
– –
0.70, 1.0, 0.82 1, 1, 1
0.67, 0.67, 0.67 –
0.72, 0.84, 0.77 0.67, 0.58, 0.62
– –
0.54, 0.69, 0.61 0.53, 0.80, 0.64
0.94, 0.98, 0.96 0.93, 0.98, 0.95
0.73, 0.80, 0.76 0.83, 0.59, 0.69
0.73, 0.80, 0.76 0.83, 0.59, 0.69
0.76, 0.91, 0.83 0.75, 0.86, 0.96
0.76, 0.91, 0.83 0.75, 0.86, 0.96
0.78, 0.84, 0.81 0.65, 0.83, 0.73
0.79, 0.94, 0.86 0.81, 0.91, 0.85
0.79, 0.91, 0.84 0.83, 0.81, 0.82
0.69, 0.85, 0.76 0.63, 0.75, 0.68
0.76, 0.94, 0.84 0.74, 0.90, 0.81
thin these tables.
Table 5
Experimental effects estimated using the wilcoxon rank sum test.
Wilcoxon rank sum test
Control: raw annotation Experiment: BoB + eHOST Oracle Signiﬁcance
Median F1-measure N Median F1-Measure N Pr>|Z|
All Annotation Types 0.91 1156 0.91 741 0.296
High Risk 1 365 1 274 <0.0001a
Patient Names 1 78 1 32 0.0389a
Health Care Provider Names 1 338 1 201 0.278
Relative Names 1 8 0.5 2 0.553
Other Person Names 0.5 11 0 106 <0.0001a
Medium Risk 1 879 1 579 0.0748
Street City 1 68 0 72 <0.0001a
State Country 0.96 48 0 64 0.0009a
Zip codes – – – – –
Deployments 0.33 2 – – –
Other Organization Names 0.5 72 0 65 0.0319a
Dates 1 533 1 342 0.195
Ages 1 764 1 493 0.992
Phone Numbers 0.58 4 1 2 0.140
Electronic Addresses – – – – –
Other ID Numbers 0.20 47 0 37 0.553
Low Risk 0.667 277 0 221 0.0002a
Health Care Unit Names 0.667 277 0 221 0.0002a
Non-PHI 0.857 729 0.995 459 0.7103
Clinical Eponyms
Anatomic structures 0.933 101 0.8 61 0.600
Devices 0.872 485 1 303 0.103
Diseases 0.919 116 1 66 0.784
Procedures 0.667 347 0.667 211 0.929
Person Relations 1 141 1 72 0.458
Bold is provided for super categories of annotation classes only and overall numbers within these tables.
a Control condition generated signiﬁcantly higher quality data than the experimental condition.
Fig. 3. PHI coverage differences as a function of annotator number.
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with other published studies [8,14,16,20,27] due to the large vari-
ety of report types used in our study and the differences in anno-
tation schema between studies. Our average prevalence of 4.0
PHI annotated per document for the MTSamples corpus is lower
than those reported using other clinical corpora such as 26 per doc-
ument from the VA [8], 22 from the 2006 i2b2 De-identiﬁcation
challenge [16], 8.79 per document from the 2012 Deleger et al.
study [14], 49 from the 2013 Hanauer et al. study [20], and 7.9
per document from a 2006 study by Dorr et al. [32]. This difference
could be due to the varied PHI types and prevalence of document
types annotated in these other studies. For instance, a general clin-
ical document containing instructions for how a patient should
continue to treat ‘‘Athlete’s foot’’ would not contain PHI.
We should note that our corpus does contain clinical informa-
tion that can be mistaken for PHI. Clinical eponyms are one such
example accounting for 27.3% of the total corpus, which is signiﬁ-
cantly higher than the 3.5% previously observed using the same
annotation schema on VA clinical documents [33].5.2. BoB-reference standard performance metrics
We observed low to moderate F1-measure for predicting low to
high risk PHI mentions. This is not surprising since this perfor-
mance is based on pre-annotations produced by BoB previously
trained using VA clinical documents and not on MTSamples
documents. Even though the performance of the baseline pre-
annotation system was poor we would expect (particularly for
medium and low risk PHI types), that a combined approach using
machine-generated pre-annotations plus the interactive annota-
tion interface would result in improvements in the quality of anno-
tated data and result in gains in annotation efﬁciency. This
expectation was not borne out for the majority of annotation types
in our study. Furthermore, annotators used the eHOST Oracle for
only a small proportion of their annotations because they found
it easier to annotate on raw clinical texts without the interactive
machine suggestions. It is not clear whether this preference was
due to the high number of false positives introduced by BoB or
related to usability issues with the eHOST Oracle. However, anno-
tator usability ratings of the eHOST Oracle based on the system
usability scale (SUS) [34] were slightly above average. Despite this
preference the number of false positives introduced using the
eHOST Oracle was very small compared with the number of false
positives introduced by BoB. Although the Oracle was not speciﬁ-
cally designed for relations it was used to annotate one or both
entities in co-referring relation pairs for annotation types repre-
senting proper names of persons. This is interesting since identify-
ing a co-referring pair ﬁrst involves identifying the entities that
should be linked.5.3. Annotator–annotator agreement
When viewed in aggregate for each PHI risk category, raw
annotation on clinical texts produced the highest inter-annotator
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false positives producing less reliable annotation between annota-
tors. However, these false positives were introduced in the major-
ity of cases due to the low baseline performance of the BoB outputs
used as pre-annotations and not via annotator interaction with the
eHOST Oracle. Moreover, even though not statistically signiﬁcant,
use of the eHOST Oracle produced higher quality data when build-
ing relation pairs between person names. Person relations IAA was
higher where BoB + eHOST was used due to the high IAA for Health
Care Provider Names and Patient Names (particularly for partial IAA)
and their high prevalence in the corpus. We are not surprised to
observe less prevalent PHI types like Relative Names and Deploy-
ments had the lowest IAA. Introducing more training instances
could boost IAA performance for these types.
5.4. Annotator performance: annotator-reference standard
performance metrics
Standard performance metrics demonstrated similar results
with the control condition producing higher quality data among
all PHI risk categories as demonstrated in Table 4 and theWilcoxon
Rank Sum Test in Table 5.
5.5. Annotation experiment
There are several lessons we learned from integrating a com-
bined approach using outputs from an untrained de-identiﬁcation
system along with an interactive interface. First, the experimental
condition did not introduce signiﬁcant gains in recall, precision,
and F1-measure. This is surprising since particular annotation
types including clinical non-PHI can easily and consistently be
found using the eHOST Oracle since they follow standard naming
conventions and were often ﬂagged as false positive BoB pre-anno-
tations (i.e. clinical eponyms and Other Organization Names). Anno-
tation on raw clinical texts produced higher quality data across all
annotation types when compared with the experiment. For some
annotation types (i.e. Other Person Names, Health Care Unit Names),
annotator agreement remained lower than expected throughout
the experiment and never plateaued. In the best of all possible
experiments annotators would train until their agreement meets
or exceeded some pre-deﬁned threshold. This brings us to several
remaining questions reserved for future experimentation. First, we
did not explore how applying a ‘‘tag a little, learn a little’’ approach
could be implemented in a practical way [20]. Second, we did
not explore ‘‘how high’’ system performance should be to opti-
mize annotator performance e.g., would higher performing pre-
annotation with precision and/or recall greater than 50% produce
better results instead of the out-of-the-box application of BoB?
The methods used for this annotation task could be modiﬁed to
ﬁt annotation of other types of information commonly found in
clinical texts including clinical entities. However, caution should
be used when pre-annotation or machine-assisted methods are
employed as a means to improve the quality of generated data
or reduce the time required to generate annotated data. This is
particularly true when an untrained system is used out-of-
the-box to produce pre-annotations with no domain adaptation.
On the one hand, providing pre-annotated information derived
from system outputs may result in human annotators either trust-
ing the pre-annotations too much in the case where system out-
puts are highly precise or missing incorrect annotations when
system outputs produce results of high recall. This is a limitation
in the way BoB outputs were used as pre-annotations in our study
since they are derived using both rules and machine learning
approaches. High performing machine learning based systems
usually require training on similar documents to those being
de-identiﬁed [20].5.6. Time comparison
Across all annotation types, we observed no statistical differ-
ences for annotation times between the experiment and control
conditions. Lack of time difference may be due to time added for
deleting false positives that could equate to the same amount of
time required to identify a PHI span in the same document that
is not reviewed using BoB + eHOST. This result is contrary to a
study by Fort and Saggot [19] that used machine pre-annotations
for POS tagging in which signiﬁcant reduction in time was
observed for the experiment, as well as a more recent study by
Lingren et al. [24] in which machine pre-annotation was employed
to annotate clinical named entities resulting in signiﬁcant reduc-
tion in annotation time and no effect on IAA or standard perfor-
mance metrics. However, our experimental results are congruent
with ﬁndings by Ogren and colleagues [23] that outputs generated
from a third-party system used as pre-annotations decreased
efﬁciency and produced little gain in data quality.
Although annotations using only the eHOST Oracle were
generated faster than the control condition alone, the lack of time
difference between experimental and control conditions may be a
consequence of combining pre-annotations with the interactive
annotation interface. Higher quality pre-annotations may intro-
duce efﬁciencies compared with annotation on raw clinical texts.
On the other hand lower quality pre-annotations certainly do not
offer a net gain in efﬁciency or annotator performance due to the
added task of modifying existing, adding missed, or deleting
spurious annotations. It is likely that the ratio of correct to incor-
rect pre-annotations must be small in order for there to be any efﬁ-
ciency gains offered by the machine-assisted approach [35].5.7. Coverage differences with added annotators
The number of annotators needed to achieve adequate recall
and precision may be dependent on various factors that should
be explored in future annotation studies. First, different clinical
documents may require more reviewers as compared with fewer.
Second, a privacy risk ranking of PHI types should be one consider-
ation for these tasks. Third, there are policy implications for the
redaction of PHI from clinical texts that extend beyond simply
removing personally identiﬁable information. A reference standard
generated by human reviewers is never perfect and the ability of
humans to reliably annotate for PHI and generate an accurate ref-
erence standard is a difﬁcult goal to achieve. Even though annota-
tors trained on the de-identiﬁcation task and tools until they
achieved a pre-deﬁned performance threshold in the training,
IAA never plateaued across either annotator training or experiment
for both control and experimental conditions for some annotation
types in our study. This indicates human annotators were still
‘‘learning’’ to correctly identify and classify some annotation types
through both the training and experiment. There are two tasks that
must go on simultaneously in the reviewers mind, ﬁrst the
reviewer must read the clinical text and second, the reviewer must
apply the guidelines and annotation schema. This observation
speaks to the complexity of a manual de-identiﬁcation task, the
difﬁculty of providing enough examples of each annotation type,
and the ability of human annotators to consistently apply an
annotation schema written in the spirit of the HIPAA Safe Harbor
method.6. Conclusions
We have demonstrated the generalizability of a manual de-
identiﬁcation task on a publicly available, heterogeneous corpus
of clinical documents, MTSamples, using an annotation schema
172 B.R. South et al. / Journal of Biomedical Informatics 50 (2014) 162–172and guidelines originally developed for a similar annotation effort
on VHA clinical documents. Based on this schema and the resulting
annotations, we determined most PHI annotations represent
expressions of medium risk of re-identiﬁcation Overall, we
observed that PHI classes can be annotated with high average
inter-annotator agreement. In this experiment, machine-assisted
annotation did not improve annotation quality for most PHI classes
and did not provide statistically signiﬁcant time-savings compared
to manual annotation of raw documents. However, we determined
that two annotators perform PHI annotation with highest F1-mea-
sure and observed diminishing PHI coverage with each added
annotator. This could be an important ﬁnding for institutions cre-
ating a de-identiﬁcation service where humans would be hired to
manually redact PHI from clinical texts. Finally, we have produced
a de-identiﬁed clinical document corpus and a reference standard
that can be used for future experimentation on NLP de-identiﬁca-
tion methods.
In the case of building a reference standard that will be used to
train automated systems for de-identiﬁcation, it is better to err on
the side of high recall considering the implications and negative
impacts of HIPAA violations on the institution providing the data.
These issues should be considered in the context of patient privacy,
potential information loss, and the workload associated with man-
ual de-identiﬁcation of clinical texts. Balancing the expectations of
existing ethical and legal responsibility with practicality and the
burdens of human review is paramount for any sound implemen-
tation of automated machine methods used for clinical text de-
identiﬁcation. This study contributes to the ongoing analysis of
human review methods used for de-identiﬁcation of clinical texts.Acknowledgments
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